Lenvaxen (Lenvatinib Mesylate INN equivalent to Lenvatinib) 4 mg

0.00$

Lenvaxen, containing Lenvatinib Mesylate, which is the International Nonproprietary Name (INN) equivalent to Lenvatinib, is a medication used to treat various cancers, including thyroid cancer and liver cancer. As a multi-kinase inhibitor, Lenvaxen works by targeting specific proteins involved in tumor growth and blood vessel formation, thereby slowing down or stopping cancer cell growth. The typical dosage of Lenvaxen is 4 mg taken orally once daily, usually with or without food. Patients may experience side effects such as hypertension, fatigue, diarrhea, decreased appetite, and nausea. Close monitoring for adverse reactions and periodic medical assessments are necessary during treatment with Lenvaxen.

 

Add to wishlist
Share

    Indications: Niraparib is prescribed for:

    • Continuation therapy for advanced ovarian cancer in patients who have responded to platinum-based chemotherapy.

    Pharmacology: Niraparib operates as a PARP inhibitor, obstructing PARP enzymes involved in DNA repair. This impediment prevents cancer cells from mending their DNA, leading to their demise.

    Dosage and Administration: The standard dose is 300 mg taken orally once daily. Adjustments may be required for Niraparib Tosylate Monohydrate equivalent to Niraparib 100 mg. It can be ingested with or without food.

    Interactions: Niraparib could interact with other drugs, emphasizing the necessity to divulge all medications, encompassing over-the-counter medications, vitamins, and herbal supplements, to healthcare providers.

    Side Effects: Common adverse reactions include nausea, vomiting, fatigue, anemia, reduced appetite, diarrhea, and abdominal pain. More severe effects might encompass bone marrow suppression and an increased risk of specific cancers.

    Precautions and Warnings: Niraparib may induce bone marrow suppression, prompting periodic blood tests to monitor blood cell counts. Patients should also be monitored for indications of new cancers.

    Overdose Effects: If an overdose occurs, supportive measures are essential. There isn’t a specific antidote, and treatment concentrates on managing symptoms.

    Product Name

    Lenvaxen

    Generic Name

    Lenvatinib Mesylate INN equivalent to Lenvatinib

    Formulation

    Capsule

    Available Pack size

    30 Capsules

    Strengths

    4 mg